Altos Labs is a biotechnology company dedicated to unraveling the deep biology of cell rejuvenation. Its ultimate goal is to develop therapies that can halt or reverse human aging at the cellular level, with the aim of reversing disease, injury, and disabilities throughout life.
The company's work sits at the intersection of several technical domains, including cellular biology, cell rejuvenation programming, machine learning, computation, and multi-scale generative modeling. It operates from research sites in the Bay Area, San Diego, and Cambridge, UK, within the biotechnology and pharmaceutical development sectors.
Altos Labs is staffed by what it describes as exceptional scientists and industry leaders. The company states it merges the best of academia and industry, combining the freedom to pursue challenging biological problems with a patient-focused drive.
